Ahn-Gook Pharmaceutical Co Ltd
001540
Company Profile
Business description
Ahn-Gook Pharmaceutical Co Ltd manufactures and markets medicines. The company's business involves the manufacture and sale of pharmaceuticals and health functional foods. Its main products include Synatura, Revotension, Levosartan, and Pevalojet.
Contact
12 Gwacheon-daero 7-gil
Prism Square 2 Building A
Gyeonggi-do, Galhyeon-dong
Gwacheon-si13840
KORT: +82 232894226
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
411
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks
Bapcor is paying for the sins of its past
Shares plunged over 17% after reporting disappointing results.
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,383.40 | 9.70 | 0.10% |
| CAC 40 | 8,206.07 | 17.48 | 0.21% |
| DAX 40 | 24,258.80 | 427.81 | 1.80% |
| Dow JONES (US) | 46,706.58 | 515.97 | 1.12% |
| FTSE 100 | 9,403.57 | 49.00 | 0.52% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,990.54 | 310.57 | 1.37% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,315.90 | 29.06 | -0.22% |
| S&P 500 | 6,735.13 | 71.12 | 1.07% |
| S&P/ASX 200 | 9,081.60 | 5.70 | 0.06% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |